CAGR of 13.6% Projected as Global Immuno-Oncology Drugs Market Grows Rapidly: Data, Insights, and Analysis from 2024 to 2029

A surge in cancer cases globally and increased investment in immuno-oncology are key factors driving the growing immuno-oncology drugs market.

What Is The Projected Market Size Of The Global Immuno-Oncology Drugs Market And Its Growth Rate?
The immuno-oncology drugs market has witnessed rapid growth over the recent years and the trend is expected to continue. Key statistics include:
• The market value was $94.16 billion in 2024 and grew to $106.92 billion in 2025 at a CAGR of 13.6%.
• This growth was driven by a rise in cancer cases, economic growth in emerging markets, increased healthcare expenditure, and pharmaceutical R&D expenditure.
• The market size is projected to grow substantially to $153.16 billion in 2029 at a CAGR of 9.4%.
• The strong upcoming growth can be attributed to increasing investments in immuno-oncology, a focus on immunotherapy drugs for cancer treatment and product innovations.

What Is Driving The Growth In The Immuno-Oncology Drugs Market?
The significant rise in cancer cases worldwide is a major factor contributing to the growth of the immuno-oncology drugs market. For example, in January 2022, the American Cancer Society predicted that there would be about 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, equating to roughly 1,670 fatalities per day. The most common types of cancer globally are lung, prostate, bowel, and female breast cancer, representing 43% of all new cancer cases. Consequently, the escalating cancer incidence rate is anticipated to spur demand for immuno-oncology drugs in the upcoming years.

Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp

Who Are the Key Players Driving Immuno-Oncology Drugs Market Growth?
Multiple major companies are operating in the immuno-oncology drugs market including:
• F. Hoffmann-La Roche Ltd.
• Merck & Co.
• Bristol-Myers Squibb Company
• Amgen Inc
• Johnson & Johnson
• AstraZeneca Plc
• Eli Lilly and Company
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.
• Arlak Biotech, Apikos Pharma
• Gritstone Oncology
• Rakuten Medical
• Rubius Therapeutics
• Allogene Therapeutics
• Celgene Corporation
• Bayer AG, Incyte Corporation
• Recepta Biopharma
• CSC Pharmaceuticals International

What Are The Key Trends In The Immuno-Oncology Drugs Market?
Key trends in the market include:
• Development of personalized oncology drugs
• Focus on developing next-generation biologics
• Development of antibody-drug conjugates
• Utilizing AI solutions
• Reducing R&D costs
• Boosting innovation and leadership through immune-oncology combination therapies
• Implementing car-t therapies to boost innovations and leadership.

What Are The Segments Of The Global Immuno-Oncology Drugs Market?
The immuno-oncology drugs market is segmented into:
1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application
3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others

Which Region Leads The Immuno-Oncology Drugs Market?
North America was the largest region in the immuno-oncology drugs market in 2024. The regions covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

What Is Covered In The Immuno-Oncology Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Immuno-Oncology Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Immuno-Oncology Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Immuno-Oncology Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Immuno-Oncology Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Customization Request for this Report: https://www.thebusinessresearchcompany.com/customise?id=3455&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.